Kidney Week 2024 | 北京大学第一医院研究成果繁星璀璨

• Correlation between PKD1 Mutation Type and Height-Adjusted Total Kidney Volume in Chinese Patients with ADPKD: Genotype-Phenotype Analysis

• A Boy with Steroid-Resistant Nephrotic Syndrome and Cortical Blindness

一例患有激素抵抗型肾病综合征和皮质盲的男孩病例

• Genome-Wide Survival Study Identifies Variants Associated with Disease Progression in IgA Nephropathy

全基因组生存研究确定了与IgA肾病疾病进展相关的突变

• Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: A Multicenter, Randomized, Open-Label Phase 1b/2 Trial

• Complement Activation Products in Kidneys of Patients with Primary Focal Segmental Glomerulosclerosis

原发性局灶节段性肾小球硬化症患者肾脏中的补体活化产物

• Phenome-Wide Mendelian Randomization Analysis of the Plasma Proteins, Immune Cell Types, and Immune Cell Traits in IgAN

• Ambient Air Pollutant Mixture, Sleep Pattern, and Incident CKD: Results from a Prospective Cohort Study

• Comparative Effectiveness of Roxadustat vs. Erythropoiesis-Stimulating Agents (ESAs) on Anemia and Kidney Outcomes among Patients with CKD: A Retrospective Cohort Study

罗沙司他与促红细胞生成素（ESA）对CKD患者贫血和肾脏结局影响的比较效果研究：一项回顾性队列研究

• TOMM7 Alleviates Diabetic Kidney Disease by Regulating PINK1/Parkin-Mediated Mitophagy via Intracellular Redistribution of PLA2G6

• Supporting Self-Management of Kidney Health in Diabetic Patients via a Novel Digital Health Intervention: Protocol for a Prospective Interventional Study

• The Difference between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate and Risk of Peripheral Artery Disease

• Glomerular Filtration Rate by Differing Measures and Prediction Utility of Peripheral Artery Disease

不同测量方法得出的肾小球滤过率以及外周动脉疾病的预测效用

• Health Services Accessibility and Clinical Outcomes in Peritoneal Dialysis: Findings from the PDTAP Study

• Relationship between Exercise and the Occurrence of Abdominal Wall Complications among Patients on Peritoneal Dialysis

运动与腹膜透析患者腹壁并发症发生之间的关系

• Founder Effect for the APOE Tokyo-Maebashi Variant in the Northern Chinese Population

• The Role of von Willebrand Factor (vWF) in the Pathogenesis of C3 Glomerulopathy (C3G)

• Perlecan Is a Novel Target of Autoantibodies in Anti-glomerular Basement Membrane Disease

• Urinary Proteomics Identify Biomarkers for Predicting Complete Remission of Proteinuria in Pediatric IgA Nephropathy

• Development of Risk-Prediction Tool for Peritoneal Dialysis-Associated Peritonitis and External Validation in the PDTAP Cohort

腹膜透析相关性腹膜炎风险预测工具的开发及在PDTAP队列中的外部验证

• Protective Effect of Ambrisentan on Proteinuria in Patients with Alport Syndrome

• Atypical ADPKD Due to Complex Genotypes of Both PKD1 and HNF1B Pathogenic Variants: An Educational Case Report

• NeflgArd Open-Label Extension: Efficacy and Safety of Nefecon in Patients with IgAN Who Completed the 2-Year Phase 3 Trial

• ALIGN Subgroup Analyses: Clinically Meaningful Urinary Protein-to-Creatinine Ratio Reductions across Subgroups

• Zanubrutinib for the Treatment of Primary Membranous Nephropathy (PMN): Results of a Single-Arm Feasibility Study

Zanubrutinib用于治疗原发性膜性肾病（PMN）：单臂可行性研究结果

• SHR6508, a Calcium-Sensing Receptor Agonist, in Patients on Hemodialysis Who Have Secondary Hyperparathyroidism: A Phase 2 Trial

• ORIGIN 3: Pivotal Ph3 Study Evaluating Effect of Atacicept vs. Placebo on Proteinuria and Kidney Function Preservation in IgAN